Ysios Capital, a leading Spanish biotechnology venture capital firm, has announced that its portfolio company Aura Biosciences Inc. has priced its initial public offering (IPO) and is trading on th...
Read moreFor the first time since its foundation, EIT Health offers the first pan-European crowdfunding platform dedicated exclusively to the healthcare sector. T
Read moreSeis investigadores e investigadoras del Campus Vall d’Hebron recibirán ayudas para la investigación en cáncer que otorga la AECC.
Read moreEste jueves, 11 de noviembre, la Asociación Española contra el Cáncer (AECC) ha entregado las Ayudas a la Investigación en Cáncer AECC 2021, en un acto celebrado en la sede de la organización en...
Read moreIn October 2019, The Andrew McDonough B+ Foundation invested for the first time in Oncoheroes Biosciences, a biotech company advancing new therapies for childhood cancer. The B+ Foundation was the fir...
Read moreSe trata de una compañía tecnológica impulsada por el Barcelonaβeta Brain Research Center (BBRC) en conjunto con los investigaodres Dr. Juan Domingo Gispert y Dr. José Luis Molinuevo.
Read moreNabil Djouder, lead researcher of the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Centre (CNIO), is receiving funding from the Spanish Association Against Cancer...
Read moreBetaScreen’s technology is based on an algorithm capable of interpreting image biomarkers from Magnetic Resonance and CT scans, which allows to identify the presence of abnormal levels of Alzheim...
Read moreThis morning at the Barcelona Science Park, the first edition of the accelerator kicked off in an event presided by Mayor Ada Colau and University of Barcelona Rector Joan Guàrdia
Read moreThe 7 IRB Barcelona projects that have been awarded funding seek to advance research into cancer, with a focus on the cancer patient and increasing survival rates.
Read moreIntegra Therapeutics (Integra Tx), a biotechnology company that is creating next-generation gene editing tools to boost the efficiency and safety of advanced therapies, has completed its first roun...
Read moreEl proyecto «Early molecular nanoDIAGnostics of Brain tumors using ImmunePET (DIAGBI)» recibirá más de 1,4 millones de euros de financiación entre 2021 y 2024 dentro de la convocatoria de Proy...
Read more